Randomized phase II study comparing neoadjuvant 5-fluorouracil/oxaliplatin/docetaxel versus docetaxel/oxaliplatin/S-1 for patients with type 4 or large type 3 gastric cancer

Future Oncology, Ahead of Print.

Source: Future Oncology - October 26, 2023 Category: Cancer & Oncology Authors: Tadayoshi Hashimoto Izuma Nakayama Manabu Ohashi Junki Mizusawa Hiroshi Kawachi Ryosuke Kita Haruhiko Fukuda Yukinori Kurokawa Narikazu Boku Takaki Yoshikawa Masanori Terashima Source Type: research